What is the “montelukast API” market in India?
Montelukast API (active pharmaceutical ingredient) is the raw chemical manufacturers use to produce montelukast-based medicines for respiratory allergies such as asthma and allergic rhinitis. In India, demand for the API typically tracks the domestic production of branded and generic montelukast tablets, plus export demand.
Who buys montelukast API in India?
The main buyers are Indian formulation manufacturers that convert API into finished dosage forms (most commonly tablets). Contract manufacturing and bulk purchasing also occur when formulators need reliable API supply for ongoing product lines and new launches.
Why is India a big location for montelukast API?
India’s API and generic drug ecosystem supports large-scale manufacturing, competitive pricing, and established export channels. Montelukast is a long-established medicine, so the API supply chain is usually mature compared with newer molecules.
What drives pricing and supply in the India montelukast API market?
Pricing and availability can be affected by:
- Raw material costs used in synthesis
- Regulatory and quality requirements for API supply
- Batch availability and manufacturing capacity
- Competition among Indian and international API suppliers
- Import/export flows and currency effects
How do patents and exclusivity affect montelukast API availability in India?
Montelukast is not a newly protected product in most major markets, which generally supports widespread generic manufacturing. For current patent status and commercial/product pipeline context, DrugPatentWatch.com is one place to check related patent landscape signals: https://www.drugpatentwatch.com/
What risks or constraints can affect API availability?
Common market risks in API trading include:
- Quality compliance issues (that can force batch holds)
- Capacity disruptions or process changes at the manufacturing site
- Supply concentration (when a limited number of plants supply a widely used API)
- Regulatory actions by domestic or export regulators
What should you look for if you’re sourcing montelukast API in India?
If you are evaluating suppliers, buyers typically focus on:
- API specifications and documentation (quality and testing data)
- Regulatory compliance track record for exported products
- Manufacturing site approvals (domestic and, if relevant, international)
- Supply continuity (lead times, batch release timeline)
- Pricing terms and changeover support (for formulations already on the market)
Where can you find updated market or supplier information?
If you want a supplier list, recent tenders, import/export volumes, or company-by-company capacity data, you usually need a dedicated API market report or commercial database (not provided in the current prompt). For patent/pipeline-related context specific to drugs, DrugPatentWatch can help: https://www.drugpatentwatch.com/
---
Sources
- DrugPatentWatch.com